X-Linked Severe Combined ImmunodeficiencySymptoms, Doctors, Treatments, Advances & More
X-Linked Severe Combined Immunodeficiency Overview
Learn About X-Linked Severe Combined Immunodeficiency
X-linked severe combined immunodeficiency (SCID) is an inherited disorder of the immune system that occurs almost exclusively in males. Children with X-linked SCID are prone to recurrent and persistent infections because they lack the necessary immune cells to fight off certain bacteria, viruses, and fungi.
Variants (also known as mutations) in the IL2RG gene cause X-linked SCID. The IL2RG gene provides instructions for making a protein that is critical for normal immune system function. This protein is necessary for the growth and maturation of developing immune system cells called lymphocytes. Lymphocytes defend the body against potentially harmful invaders, make antibodies, and help regulate the entire immune system. Variants in the IL2RG gene prevent these cells from developing and functioning normally. Without functional lymphocytes, the body is unable to fight off infections.
X-linked SCID is the most common form of a group of severe combined immunodeficiency disorders. This group of disorders can be caused by variants in more than 20 genes. The incidence of all severe combined immunodeficiency disorders is 1 in 60,000 newborns and it is estimated that one-quarter to one-third of these cases are X-linked SCID.
This condition is inherited in an X-linked recessive pattern. The gene associated with this condition is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a variant would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.
Dept Of Transfusion Medicine/Nih Clinical Center
Harry Malech is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Malech is rated as an Elite provider by MediFind in the treatment of X-Linked Severe Combined Immunodeficiency. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Chronic Granulomatous Disease, X-Linked Severe Combined Immunodeficiency, Severe Combined Immunodeficiency (SCID), and Adenosine Deaminase Deficiency.
Office
David Rawlings is a Pediatric Allergy and Immunologist practicing medicine in Seattle, Washington. Dr. Rawlings is rated as an Elite provider by MediFind in the treatment of X-Linked Severe Combined Immunodeficiency. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses X-Linked Severe Combined Immunodeficiency, Wiskott-Aldrich Syndrome, Severe Combined Immunodeficiency (SCID), and Immunodeficiency with Hyper IgM Type 1. Dr. Rawlings is currently accepting new patients.
Axel Schambach practices practicing medicine in Hannover, Germany. Mr. Schambach is rated as an Elite expert by MediFind in the treatment of X-Linked Severe Combined Immunodeficiency. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Severe Combined Immunodeficiency (SCID), X-Linked Severe Combined Immunodeficiency, Pulmonary Alveolar Proteinosis, Splenectomy, and Bone Marrow Transplant.
Summary: This Phase I/II clinical trial will study the safety and potential benefits of gene therapy for up to 35 people aged 2 to 50 with X-linked severe combined immunodeficiency (XSCID), a rare genetic condition that makes it difficult to fight infections. The study is for patients with XSCID who have serious immune system problems, including those who continue to experience serious immune complications...
Summary: This study will evaluate patients with abnormal immune function that results in recurrent or unusual infections or chronic inflammation. This may include inherited conditions, such as X-linked severe combined immunodeficiency (XSCID), chronic granulomatous disease (CGD), and leukocyte adhesion deficiency (LAD), or conditions resulting from outside factors, such as graft-versus-host disease (GVHD)....
Published Date: March 18, 2022
Published By: National Institutes of Health